Boostrix FDA Approval History
FDA Approved: Yes (First approved May 3, 2005)
Brand name: Boostrix
Generic name: tetanus, diphtheria, acellular pertussis vaccine (Tdap)
Company: GlaxoSmithKline Biologicals
Treatment for: Diphtheria Prophylaxis, Tetanus Prophylaxis, Pertussis Prophylaxis
Boostrix is a combination vaccine that provides a booster immunization against pertussis (whooping cough) in combination with tetanus and diphtheria.
Development Timeline for Boostrix
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.